Sunshine Biopharma Stock Quote SBFM - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.935

Bid

0.935

Ask

0.95

Volume

92,579

0.00 Day's Range 0.00

0.75 52 Week Range 140.00

Market Cap

25.422M

Previous Close

0.9897

Open

Last Trade

393

0.935

(formt)

Last Trade Time

06:26:01

Financial Volume

VWAP

Average Volume (3m)

27,639,700

Shares Outstanding

25,678,290

Dividend Yield

PE Ratio

-5.64

Earnings Per Share (EPS)

-0.18

Revenue

24.09M

Net Profit

-4.51M

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of ... Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). Show more

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.sunshinebiopharma.com

Headquarters

Montreal, Quebec, Can

Founded

1970

Sunshine Biopharma Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker SBFM. The last closing price for Sunshine Biopharma was $0.99. Over the last year, Sunshine Biopharma shares have traded in a share price range of $ 0.75 to $ 140.00.

Sunshine Biopharma currently has 25,678,290 shares outstanding. The market capitalization of Sunshine Biopharma is $25.42 million. Sunshine Biopharma has a price to earnings ratio (PE ratio) of -5.64.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.095	11.3095238095	0.84	1.03	0.8	6587822	0.91844363	CS
4	-9.065	-90.65	10	10	0.75	10830144	3.75309162	CS
12	-5.705	-85.9186746988	6.64	14.25	0.75	27639700	7.79065121	CS
26	-27.065	-96.6607142857	28	31.86	0.75	13048505	7.95037762	CS
52	-51.855	-98.228831218	52.79	140	0.75	6830821	12.00575099	CS
156	-274.065	-99.66	275	987	0.75	4594710	168.72874523	CS
260	-274.065	-99.66	275	987	0.75	4594710	168.72874523	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AIREreAlpha Tech Corporation	$ 1.24 (44.78%)	1.74M
ESPREsperion Therapeutics Inc	$ 2.82 (33.02%)	1.21M
DYNTDynatronics Corp	$ 0.58 (25.11%)	76
JUNEJunee Ltd	$ 5.88 (24.05%)	22
FGENFibroGen Inc	$ 1.37 (18.10%)	2.53M
GPGreenPower Motor Company Inc	$ 1.20 (-34.07%)	21.8k
AGRIAgriFORCE Growing Systems Ltd	$ 0.101 (-30.06%)	383.05k
HSDTHelius Medical Technologies Inc	$ 1.94 (-19.83%)	50.13k
ASNSActelis Networks Inc	$ 0.5001 (-18.30%)	421
CELHCelsius Holdings Inc	$ 65.75 (-16.06%)	117.61k
FFIEFaraday Future Intelligent Electric Inc	$ 0.0435 (5.33%)	11.64M
FGENFibroGen Inc	$ 1.37 (18.10%)	2.53M
AIREreAlpha Tech Corporation	$ 1.24 (44.78%)	1.74M
TCBPTC BioPharm Holdings PLC	$ 1.56 (7.59%)	1.61M
LYRALyra Therapeutics Inc	$ 0.4419 (-15.26%)	1.4M